Continuous Pre-uterine Wound Infiltration Versus Intrathecal Morphine for Postoperative Analgesia After Cesarean Section
Postoperative Pain
About this trial
This is an interventional treatment trial for Postoperative Pain focused on measuring cesarean section, spinal anesthesia, continuous wound infiltration, intrathecal morphine, oral morphine
Eligibility Criteria
Inclusion Criteria:
- Elective Cesarean section
- Spinal anesthesia
- Singleton
- ASA ( Physical status score) 1 to 3
Exclusion Criteria:
- Age <18yrs
- BMI ≥ 45 kg/m2 or weight < 45 kg
- Refusal to consent
- Urgent cesarean section
- Allergy to a medication used in the protocol
- Impaired hemostasis ou current infection
- Contra indication or failure of spinal anesthesia
Sites / Locations
- Maternité Régionale Universitaire (MRU)Recruiting
Arms of the Study
Arm 1
Arm 2
Arm 3
Experimental
Active Comparator
Experimental
Continuous wound infiltration alone
Intrathecal moprhine alone
Intrathecal morphine&wound infiltration
Spinal anesthesia will be performed with 10 mg bupivacain 0.5% hyperbaric, 3 μg sufentanil and 1 ml sodium chloride 0.9% (without morphine). Patient will then receive a continuous wound infiltration of ropivacaine 0.2% 8 ml/H via a preperitoneal catheter.
Spinal anesthesia will be performed with 10 mg bupivacain 0.5% hyperbaric, 3 μg sufentanil and 0.1mg morphine. Patient will then receive a continuous wound infiltration of sodium chloride 0.9% 8 ml/H via a preperitoneal catheter.
Spinal anesthesia will be performed with 10 mg bupivacain 0.5% hyperbaric, 3 μg sufentanil and 0.1mg morphine. Patient will then receive a continuous wound infiltration of ropivacaine 0.2% 8 ml/H via a preperitoneal catheter.